CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
Medipacs
Medipacs logo

Medipacs

Medipacs, Inc. develops and manufactures non-mechanical infusion pumps for precise drug delivery.

San Diego, CA, US🇺🇸
Founded
2004
Overview
Compare
Fundraising
Employees
Library

Medipacs, Inc., founded in Tucson, AZ, is dedicated to revolutionizing drug delivery through the development and manufacturing of non-mechanical infusion pumps. The company's core mission is to enhance patient care by providing precise and reliable drug delivery systems. Medipacs' products are designed to administer a variety of medications, including biologics, insulin, hormones, fertility drugs, anti-coagulation drugs, and pain medication. Their market focus is on healthcare providers and patients requiring consistent and accurate medication administration.

Notable figures affiliated with Medipacs include Mark Banister, who can be contacted for further information about the company. Medipacs has achieved significant milestones in the medical device industry by offering innovative solutions that improve the quality of life for patients. Their non-mechanical infusion pumps have garnered attention for their precision and reliability, making a substantial impact on the healthcare sector.

Medipacs - Similar Companies

InfuSystem Holdings logo

InfuSystem Holdings

infusystem.com

MedApptic logo

MedApptic

medapptic.com

LifeMedix logo

LifeMedix

lifemedix.com

Mercator Medsystems logo

Medipacs - Quick Facts

Who are Medipacs' competitors?

Companies similar to Medipacs include InfuSystem Holdings, MedApptic, LifeMedix and Mercator Medsystems.

When was Medipacs founded?

Medipacs was founded in 2004.

Where is Medipacs' headquarters located?

Medipacs' headquarters is located in San Diego, CA, US.

When was Medipacs' last funding round?

Medipacs' most recent funding round was for $2M (USD) in October 2014.

How much disclosed funding has Medipacs raised?

As of Oct 30, 2014, Medipacs has disclosed funding of $4.7M (USD). Undisclosed round amounts are excluded.

Medipacs - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Medical Devices

How many employees does Medipacs have?

Medipacs has 9 employees as of Feb 4, 2024.

Geographic Exposure
  • United States
Revenue
  • Transactional
Customer
  • Enterprise
Main Product
  • Infusion Pumps
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 1 more industry code
NAICS
  • 623000Nursing and Residential Care Facilities

Mercator Medsystems

mercatormed.com

Cam Med logo

Cam Med

RxActuator logo

RxActuator

Fluid Synchrony logo

Fluid Synchrony

fluidsynchrony.com

Enable Injections logo

Enable Injections

B. Braun Medical logo

B. Braun Medical

bbraunusa.com

Medicreations logo

Medicreations

medicreations.com

Credence MedSystems logo

Credence MedSystems

Pocket Clinic logo

Pocket Clinic

pocketclinic.life

Fluonic logo

Fluonic

Flowonix Medical logo

Flowonix Medical

flowonix.com

Sigma International General Medical Apparatus logo

Sigma International General Medical Apparatus